文献速递心脑血管急症

患者参与曼彻斯特急性冠脉综合征(MACS)决策规则随机对照试验体验的探索

An exploration of patients' experiences of participation in a randomised controlled trial of the Manchester Acute Coronary Syndromes (MACS) decision rule.
PubMed 文献 · Emerg Med J · 2017-05-12
一句话结论患者对参与MACS决策规则与标准治疗对照的随机试验总体持积极态度,但到达时疼痛或焦虑者认为初次邀请参与过早,应给其时间平复。

本研究为嵌套于一项比较MACS决策规则与标准治疗的试点随机对照试验(RCT)中的定性研究,采用半结构化访谈和框架法分析。10名受访者认为参与试验总体可接受,除1人外均愿向他人推荐参与。到达时疼痛或焦虑的患者报告初次邀请参与有时过早,给予时间平复后邀请是受欢迎的。受访者欢迎参与试验能更主动参与医疗、减少不必要等待时间、可能更早回家及获得随访。尽管部分人对医学研究持怀疑态度,但因认同该领域研究必要性且认为干预无创而愿意参与。结论为患者对参与该RCT持积极态度,并识别出若干可改进试验设计的方面,应在未来大型试验规划中考虑。

要点

  • 10名受访者认为参与MACS规则与标准治疗对照的RCT总体可接受,除1人外均推荐他人参与。
  • 到达时疼痛或焦虑的患者报告初次邀请参与试验有时过早,给予时间平复后邀请受欢迎。
  • 受访者欢迎参与试验带来的更主动参与医疗、减少不必要等待时间、可能更早回家及获得随访。
  • 部分受访者对医学研究持怀疑态度,但因认同该领域研究必要性且认为干预无创而愿意参与。
  • 作者认为已识别若干可改进试验设计的方面,应在未来大型试验规划中考虑。

适用人群与场景

  • 嵌套于比较MACS决策规则与标准治疗的试点RCT中,同意参与并接受半结构化访谈的参与者。

研究设计与关键结果

  • 定性研究嵌套于试点RCT,10名受访者接受半结构化访谈,采用框架法和归纳法分析。
  • 受访者表达参与试验总体可接受,除1人外均推荐他人参与。
  • 到达时疼痛或焦虑的患者报告初次邀请参与有时过早,给予时间平复后邀请受欢迎。
  • 受访者欢迎参与试验能更主动参与医疗、减少不必要等待时间、可能更早回家及获得随访。
  • 部分受访者对医学研究持怀疑态度,但因认同该领域研究必要性且认为干预无创而愿意参与。

证据类型、等级与局限

  • 证据类型:嵌套于试点RCT的定性研究(半结构化访谈)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为已识别若干可改进试验设计的方面,应在未来大型试验规划中考虑。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: As an important part of a pilot study to determine the feasibility of a large randomised controlled trial (RCT) comparing use of the Manchester Acute Coronary Syndromes (MACS) decision rule with standard care, we aimed to explore patient attitudes and potential barriers to participation in a trial of this nature.

METHODS: We conducted a qualitative study nested within a pilot RCT comparing use of the MACS rule (which could enable some patients with chest pain to be discharged earlier) with standard care. Semi-structured interviews with consenting participants were conducted with reference to a bespoke topic guide. Interviews were audio recorded, transcribed verbatim and analysed using the Framework method with an inductive approach.

RESULTS: The 10 interviewees expressed that participation in the trial was generally acceptable. All but one recommended participation to others. Participants who were in pain or anxious at the time of arrival reported that the initial invitation to participate in the trial was sometimes made too early. The approach was welcome, providing they had been given time to settle. Interviewees welcomed the opportunity that trial participation offered for them to play a more active role in their healthcare and to reduce unnecessary waiting time. Participants appeared to like the fact that participation in the trial might mean they could return home sooner and welcomed the provision of follow-up. Although several participants described being generally sceptical of medical research, they were amenable to participation in this trial. This appears to be because they agreed with the need for research in this field and perceived the intervention as non-invasive.

CONCLUSIONS: Patients were positive about their participation in this RCT comparing the MACS rule with standard care. A number of areas for improving trial design were identified and should be considered in the planning of future large trials.

TRIAL REGISTRATION: ISRCTN 86818215 RESEARCH ETHICS COMMITTEE REFERENCE: 13/NW/0081 UKCRN REGISTRATION ID: 14334.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. van den Berg P, Kendal S, Alderson HV, et al. An exploration of patients' experiences of participation in a randomised controlled trial of the Manchester Acute Coronary Syndromes (MACS) decision rule. Emerg Med J. 2017. PMID: 28500089. doi:10.1136/emermed-2016-206073

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。